Meloxicam Pregnancy and Breastfeeding Warnings
Meloxicam is also known as: Mobic
Meloxicam Pregnancy Warnings
Meloxicam has been assigned to pregnancy category C prior to 30 weeks gestation and category D starting at 30 weeks gestation by the FDA. Animal data have revealed evidence of heart defects and embryolethality after extraordinary doses (64.5 times and 5.4 times the maximum recommended human dose (MRHD), based on body surface area conversions). Animal data have failed to reveal evidence of teratogenicity after oral doses equivalent to 2.2 times the MRHD; however there was an increased rate of stillbirths after oral doses that approximated the MRHD. Animal data have also revealed a reduction in birth index, live births, and neonatal survival at doses less than the MRHD. Meloxicam crosses the placental barrier. Prior to 30 weeks gestation, meloxicam should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Starting at 30 weeks gestation, meloxicam and other NSAIDs should be avoided in pregnant women as premature closure of the ductus arteriosus in the fetus may occur. If meloxicam is used during this time period in pregnancy, the patient should be informed of the potential hazard to the fetus.
Meloxicam Breastfeeding Warnings
There are no data on the excretion of meloxicam into human milk; however, meloxicam was excreted in the milk of lactating rats at concentrations higher than those in plasma. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the nursing mother.
- Meloxicam use while Breastfeeding (in more detail)
- Meloxicam Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.